TTR and ovarian carcinoma: Thus, to fully validate the specificity of TTR or any of its fragments as a biomarker for ovarian cancer, a careful selection of controls has to be implemented, including consideration of nutritional status and the presence of inflammatory processes especially the possible influence of various hepatic diseases.